Ellipsis Health Announces Appointment of Jeff Clarke to Board of Directors

AI-Generated Vocal Biomarker Tech company appoints new BoD

Ellipsis Health has appointed Jeff Clarke to its Board of Directors. Clarke is an industry veteran with a proven track record in the technology and services industries.

“As Ellipsis Health works to bring AI-powered innovation to mental health care, we are delighted to add Jeff to our Board,” said Mainul Mondal, founder and CEO, Ellipsis Health. “Jeff’s deep experience and insights will be invaluable to Ellipsis Health as we expand our reach and scale our solutions.”

Clarke is an experienced leader and industry veteran with deep domain expertise. Clarke currently serves as interim CEO of Doxim, a customer communications management and engagement technology provider. Previously, he was the Executive Chairman and interim CEO of FTD, LLC, a private company controlled by Nexus Capital. Prior, Clarke spent five years as CEO of Eastman Kodak Company. He has also held numerous other C-level roles within the technology industry, including CEO, Chairman and Executive Chair positions at Travelport Limited, a private company controlled by the Blackstone Group. He served as Chief Operating Officer for CA Software, Executive Vice President of Global Operations at Hewlett-Packard, and CFO at Compaq Computer. Jeff also serves on the Board of Directors of FTD, LLC and Columbia Care. Mr. Clarke is a former director at Autodesk, Compuware, Docker, Generate Life Sciences, Orbitz Worldwide, Red Hat and UTStarcom.

“It is a privilege to join the Ellipsis Health Board of Directors,” said Jeff Clarke. “I’m excited to work closely with the Board, Mainul and the management team in this innovative and groundbreaking company.”